When was Oxipit founded?

Oxipit was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Oxipit located?

Oxipit is headquartered in Vilnius, Lithuania. It is registered at 21750 HARDY OAK BLVD STE 104,SAN ANTONIO,TX,78258,15.

Who is the current CEO of Oxipit?

Gediminas Peksys of Oxipit. They have also founded 1 company.

How many employees does Oxipit have?

As of Jun 30, 2026, the latest employee count at Oxipit is 20.

Is Oxipit a funded company?

Oxipit is a funded company, having raised a total of $6.69M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 25, 2018.

When was the latest funding round of Oxipit?

Oxipit's latest funding was a $***** Series A round on Jan 20, 2023, with participation from 3 investors.

Where does Oxipit rank among its competitors?

Oxipit ranks 2nd amongst 836 active competitors, of which 167 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Carpl, which secured $10M in Jul, 2026.

Who are the top competitors of Oxipit?

Oxipit's top competitors include AIdoc, Subtle Medical and ScreenPoint. Among them, Carpl secured the most recent funding round in July, 2026.

Oxipit - 2026 Company Profile, Team, Funding & Competitors

Oxipit is an acquired company based in Vilnius (Lithuania), founded in 2017 by Darius Barusauskas, Naglis Ramanauskas, Gediminas Peksys and Darius Barušauskas. It operates as a Developer of medical imaging software for automated radiology diagnostic support. Oxipit has raised $6.69M in funding from investors like Practica Capital, CoInvest Capital and Taiwania Capital. The company has 836 active competitors, including 167 funded and 47 that have exited. Its top competitors include companies like AIdoc, Subtle Medical and ScreenPoint.

Company Details

Developer of medical imaging software for automated radiology diagnostic support. This technology analyzes medical images to identify abnormalities and generate reports for clinical review. The software integrates into existing diagnostic workflows to assist with the assessment of chest X-rays, computed tomography scans, and musculoskeletal imaging studies. These tools provide automated analysis to facilitate the identification of findings within diagnostic imaging procedures.

Website: oxipit.ai
Social
Email ID: *****@oxipit.ai
Registered Address: 21750 HARDY OAK BLVD STE 104,SAN ANTONIO,TX,78258,15

Key Metrics

Founded Year

2017

Location

Vilnius, Lithuania

Stage

Acquired

Total Funding

$6.69M in 4 rounds

Latest Funding Round

Series A, Jan 20, 2023, $*****

Investors

Practica Capital & 5 more

Ranked

2^nd among 836 active competitors

Employee Count

20 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2408 more

Exit Details

Acquired by Sectra (Mar 05, 2026)

View Oxipit's full profile

Oxipit is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
FORMSPREE, INC. CIN: 32055055415 , United States, Active	Oct 11, 2018	-	-	-

Oxipit got acquired by Sectra on Mar 05, 2026.

Click here to take a look at Oxipit's acquisition in detail

Oxipit has raised a total funding of $6.69M over 4 rounds. Its first funding round was on Jun 25, 2018. Its latest funding round was a Series A round on Jan 20, 2023 for $*****. 3 investors participated in its latest round. Oxipit has 6 institutional investors.

Here is the list of recent funding rounds of Oxipit:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 20, 2023	3784219	Series A	9319893	5281684	7668923	5453945
Jul 16, 2019	6498354	Seed	9472076	9995025	8644389	5195340
Nov 16, 2018	2362650	Grant (prize money)	6318087	1383443	9207039	EIT Health

Access funding benchmarks and valuations. Sign up today!

View details of Oxipit's funding rounds and investors

The founders of Oxipit are Darius Barusauskas, Naglis Ramanauskas, Gediminas Peksys and Darius Barušauskas. Gediminas Peksys is the CEO of Oxipit.

Here are the details of Oxipit's key team members:

Darius Barusauskas: Co-Founder of Oxipit.
Contact Info: 1 email address
Naglis Ramanauskas: Co-Founder & CMO of Oxipit.
Contact Info: 1 email address
Gediminas Peksys: Co-Founder & CEO of Oxipit.
Contact Info: 1 email address
Darius Barušauskas: Co-Founder & Data Scientist of Oxipit.

View details of Oxipit's Founder profiles and Board Members

Oxipit's employee count trend

Oxipit has 20 employees as of Jun 26. Here is Oxipit's employee count trend over the years:

Uncover Oxipit's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oxipit include AIdoc, Subtle Medical and ScreenPoint. Here is the list of Top 10 competitors of Oxipit, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	General Catalyst, AIC & 35 others	69/100
2nd	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Taiwania Capital, Practica Capital & 4 others	66/100
3rd	Subtle Medical 2017, Palo Alto (United States), Series C	AI-driven solutions for medical diagnostic imaging	$86M	Bessemer Venture Partners, 3E Bioventures Capital ... & 27 others	65/100
4th	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Insight Partners, Siemens & 3 others	64/100
5th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
6th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Open Field Capital, Khosla Ventures & 12 others	62/100
7th	Carpl 2018, Delhi (India), Series A	AI-powered radiology and deployment platform	$16M	Stellaris, IFC & 7 others	62/100
8th	IXICO 2004, London (United Kingdom), Public	AI-based medical image management and analysis solutions for healthcare organizations	-	Leonne International, IP Group & 3 others	62/100
9th	Vara 2016, Berlin (Germany), Series A	Provider of AI-based breast cancer screening software for clinics	$20.3M	FJH, IBB Ventures & 12 others	61/100
10th	Us2.ai 2017, Singapore (Singapore), Series A	AI-powered tool for the detection of heart risk	$19.1M	EDBI, IHH Healthcare Berhad & 15 others	61/100